Device in the form of a bandage patch with ingredients for bug bite relief
US-2024335326-A1 · Oct 10, 2024 · US
US9883974B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9883974-B2 |
| Application number | US-201013518666-A |
| Country | US |
| Kind code | B2 |
| Filing date | Dec 28, 2010 |
| Priority date | Dec 28, 2009 |
| Publication date | Feb 6, 2018 |
| Grant date | Feb 6, 2018 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A process for preparing a disinfecting wound dressing for the protection of wounds, such as burn wounds, ulcers and cuts, the process comprising the steps of providing a yarn-based substrate, subjecting a surface of the substrate to a plasma environment, thereby providing non-leaching and biocidal features to the substrate surface by exposing the substrate surface to an antimicrobial active compound reaction.
Opening claim text (preview).
The invention claimed is: 1. A disinfecting wound dressing for the protection of wounds, such as burn wounds, ulcers and cuts, comprising: a yarn-based substrate layer composed of filaments of “x”, “v”, “w”, “y”, hexachannel, or tetrachannel form, having non-leaching and biocidal features, provided by exposing said substrate layer to a reaction with an antimicrobial active compound comprising subjecting the surface of the substrate to an environment resulting in either chain-transfer activation, radiation activation, photochemical activation, and/or chemical activation; a wound contact layer preventing the wound dressing from sticking to a wound, wherein said contact layer is combined with or identical to said substrate layer and wherein said combined substrate and contact layers also comprises absorbing and water evaporating properties. 2. The wound dressing according to claim 1 , further including a top layer provided with a structure preventing micro-organisms from entering the wound dressing, and having non-leaching and biocidal features. 3. The wound dressing according to claim 1 , wherein a top layer contains a layer of nanofibres. 4. The wound dressing according to claim 1 , wherein the antimicrobial active compound includes a quaternary ammonium moiety. 5. The wound dressing according to claim 4 , wherein the antimicrobial active compound is selected from the group consisting of triclosan, triclcarban, chlorhexidine, chloroxylenol, chitosan acetate, zinc sulphadiazine, and sodium dichloroisocyanurate. 6. A disinfecting wound dressing for the protection of wounds, such as burn wounds, ulcers and cuts, comprising: a yarn-based substrate layer composed of filaments of “x”, “v”, “w”, “y”, hexachannel, or tetrachannel form, having non-leaching and biocidal features, provided by exposing said substrate layer to a reaction with an antimicrobial active compound comprising subjecting the surface of the substrate to an environment resulting in either chain-transfer activation, radiation activation, photochemical activation, and/or chemical activation; a wound contact layer preventing substantial penetration of cream or ointment in the wound dressing and having a feature of non-sticking to a dried cream or ointment in the case cream or ointment is applied, wherein said contact layer may be combined with or identical to the substrate layer, and wherein said combined substrate and contact layer also comprises absorbing and water evaporating properties. 7. The wound dressing according to claim 6 , further including a top layer provided with a structure preventing micro-organisms from entering the wound dressing, and having non-leaching and biocidal features. 8. The wound dressing according to claim 6 , wherein the top layer contains a layer of nanofibres. 9. The wound dressing according to claim 6 , wherein the antimicrobial active compound includes a quaternary ammonium moiety. 10. The wound dressing according to claim 9 , wherein the antimicrobial active compound is selected from the group consisting of triclosan, triclcarban, chlorhexidine, chloroxylenol, chitosan acetate, zinc sulphadiazine, and sodium dichloroisocyanurate.
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics · CPC title
not adhering to the wound · CPC title
characterised by way of knitting or weaving · CPC title
Corona discharge or low temperature plasma · CPC title
Deodorants or malodour counteractants, e.g. to inhibit the formation of ammonia or bacteria · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.